IB IBRX ImmunityBio, Inc. Common Stock Loading... : Bullish and Bearish Analyst Opinions

The author lists favorite stocks by sector as a thematic watchlist without explicitly stating current positions or forward calls, so each ticker is indexed as watch.

The author lists favorite stocks per sector as a thematic watchlist without explicitly stating current positions or forward calls, so all tickers are indexed as watch.

The author outlines a hypothetical long-term portfolio of nine names built for asymmetric upside, implying a bullish conviction on each ticker as core holdings.

Long IBRX as a speculative biotech pick in the author's retirement list.

Anktiva approved across 33 countries; portfolio position.

Bought IBRX not too long ago and plans to add to position.

The tweet expresses sympathy regarding a tragic event while mentioning tickers without providing a financial outlook.

Despite an FDA warning letter causing a sharp price drop, the author views the decline as a buying opportunity for long-term investors.

Neuner mentions he told people to invest in ImmunityBio (IBRX) because they "may have just found a cure for cancer." He uses this to illustrate the necessity of a strong "Why" for investing. Unlike Bitcoin's currently muddied narrative, a biotech breakthrough offers a clear, compelling reason for capital allocation. LONG based on the "strong narrative" thesis. Clinical trial failures or regulatory rejections (standard biotech binary risk).

The stock is undervalued because its price has not yet reflected the company's positive clinical progress.

The speaker states a "Gamma squeeze incoming" for IBRX. A gamma squeeze is a rapid price increase driven by market makers hedging their short gamma exposure from sold call options. As the stock price rises, they must buy more shares, pushing the price even higher in a feedback loop. The user is extremely bullish on IBRX in the very short term, anticipating a rapid, options-driven price surge. Gamma squeezes are speculative, difficult to time, and can fail to materialize. If the expected buying pressure doesn't occur, the stock could fall, and any options purchased would lose value rapidly.